Literature DB >> 8821162

Mycetoma.

M R McGinnis1.   

Abstract

Mycetoma is a chronic infectious disease, most commonly caused by Madurella mycetomatis, that remains localized, involves cutaneous and subcutaneous tissue, fascia, and bone, and is noncontagious. The disease is characterized by tumefaction, draining sinuses, and the presence of sclerotia. The 31 fungi known to cause mycetoma are associated with soil and woody plants. A chronic, tumor-like deforming disease develops during subsequent years following the introduction of the etiologic agent via localized trauma. Combined surgical and medical management with ketoconazole results in the best outcome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8821162     DOI: 10.1016/s0733-8635(05)70329-6

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  21 in total

1.  Painless foot swelling with a chronic purulent discharge.

Authors:  D Papaioannides; N K Akritidis
Journal:  West J Med       Date:  2001-02

2.  Late complication after tropic storm accident: subcutaneous and intracranial actinomycetoma.

Authors:  Shyam B Verma; Suresh Nayak; Ravindra K Pasale; Thomas Kittner; Uwe Wollina
Journal:  Int Wound J       Date:  2008-09-19       Impact factor: 3.315

3.  Case report: Non-invasive management of Madura foot with oral posaconazole and ciprofloxacin.

Authors:  Amit M Sharma; Namita Sharma; Amritpal Nat; Meghan Rane; Timothy P Endy
Journal:  Am J Trop Med Hyg       Date:  2014-10-27       Impact factor: 2.345

4.  A rare cause of gastric perforation-Candida infection: a case report and review of the literature.

Authors:  Nalini Gupta
Journal:  J Clin Diagn Res       Date:  2012-11

5.  Coelomycetous Fungi in the Clinical Setting: Morphological Convergence and Cryptic Diversity.

Authors:  Nicomedes Valenzuela-Lopez; Deanna A Sutton; José F Cano-Lira; Katihuska Paredes; Nathan Wiederhold; Josep Guarro; Alberto M Stchigel
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

6.  Testing of the in vitro susceptibilities of Madurella mycetomatis to six antifungal agents by using the Sensititre system in comparison with a viability-based 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5- [(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) assay and a modified NCCLS method.

Authors:  Wendy W J van de Sande; Ad Luijendijk; Abdalla O A Ahmed; Irma A J M Bakker-Woudenberg; Alex van Belkum
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

7.  Genotyping of Madurella mycetomatis by selective amplification of restriction fragments (amplified fragment length polymorphism) and subtype correlation with geographical origin and lesion size.

Authors:  Wendy W J van de Sande; Roy Gorkink; Guus Simons; Alewijn Ott; Abdalla O A Ahmed; Henri Verbrugh; Alex van Belkum
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

8.  Rapid and Robust Identification of the Agents of Black-Grain Mycetoma by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry.

Authors:  Mark Fraser; Andrew M Borman; Elizabeth M Johnson
Journal:  J Clin Microbiol       Date:  2017-06-07       Impact factor: 5.948

9.  Phaeohyphomycosis Caused by a Novel Species, Pseudochaetosphaeronema martinelli.

Authors:  Sarah A Ahmed; Nicole Desbois; D Quist; C Miossec; Carlos Atoche; Alexandro Bonifaz; G Sybren de Hoog
Journal:  J Clin Microbiol       Date:  2015-07-01       Impact factor: 5.948

10.  Molecular detection and identification of agents of eumycetoma: detailed report of two cases.

Authors:  Abdalla O A Ahmed; Nicole Desplaces; Philippe Leonard; Fred Goldstein; Sybren De Hoog; Henri Verbrugh; Alex van Belkum
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.